NeuVasQ Biotechnologies
Latest round
- Series A
Last raised
- Jul 2021
Total raised
- $18M
Investors
- 5
About NeuVasQ Biotechnologies
Based in Charleroi, Belgium, and founded in 2021 as a spin-off of the Université Libre de Bruxelles (ULB) and Prof. Benoit Vanhollebeke, NeuVasQ Biotechnologies operates as a biotechnology company that develops novel therapies to restore blood-brain barrier function in acute neurological disorders. The firm works in developing pharmaceuticals and novel therapies to restore blood-brain barrier (BBB) functions to help restore the lost functionality to the neurovasculature system usually seen in acute neurological disorders such as stroke, epilepsy, and neurodegenerative diseases like Alzheimer’s.
Who invested in NeuVasQ Biotechnologies
5 investors across 1 round
See all investors in NeuVasQ Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 29, 2021
Amount
$18M
Investors
Questions about NeuVasQ Biotechnologies
Who invested in NeuVasQ Biotechnologies?
NeuVasQ Biotechnologies has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeuVasQ Biotechnologies raised?
NeuVasQ Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NeuVasQ Biotechnologies last raise money?
NeuVasQ Biotechnologies's most recent round on record is a Series A, in Jul 2021.
What does NeuVasQ Biotechnologies do?
Based in Charleroi, Belgium, and founded in 2021 as a spin-off of the Université Libre de Bruxelles (ULB) and Prof.
Where is NeuVasQ Biotechnologies headquartered?
NeuVasQ Biotechnologies is headquartered in Charleroi, Belgium.
Which VCs invest in companies like NeuVasQ Biotechnologies?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at NeuVasQ Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NeuVasQ Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.